在心血管代谢共病患者中实施生活方式工具包:SHRADDHA-CMM整群随机III型实施研究方案
本研究为在印度喀拉拉邦开展的整群随机III型实施研究,纳入≥18岁心血管代谢共病(CMM)成人,实施基于WHO-HEARTS框架的文化适配生活方式工具包,样本量2000人、18个整群,随访24个月,采用重复测量方差分析和多层模型意向性分析,并探索代际预防维度。
要点
- 针对印度CMM人群的文化适配生活方式工具包实施研究。
- 采用整群随机III型实施研究设计,样本2000人、18个整群。
- 干预整合饮食、运动、压力管理、戒烟限酒和服药依从性。
核心结论
- 该研究旨在填补印度CMM人群生活方式干预实施研究的空白,并探索代际预防维度。
研究设计与样本
- 研究为双臂非盲整群随机对照试验,纳入≥18岁、经知情同意并同意随访的CMM成人,CMM定义为糖尿病、高血压、卒中或冠心病中≥2种共存。
- 研究依托印度喀拉拉邦Ernakulam地区ENDIRA队列开展,样本量2000人,分布于18个整群,研究时长24个月。
- 统计分析采用重复测量方差分析和多层模型,采用意向性分析。
关键数值与推荐
- CMM定义为糖尿病、高血压、卒中或冠心病中≥2种共存。
- 纳入标准为年龄≥18岁、提供知情同意并同意随访。
- 干预为SHRADDHA生活方式工具包,整合饮食、体力活动、压力管理、戒烟限酒和服药依从性指导,依托一线卫生工作者和数字健康平台实施。
- 测量采用即时检验设备和数字工具,样本量2000人、18个整群,研究时长24个月。
临床怎么用
- 依托一线卫生工作者和数字健康平台,在社区层面实施文化适配的生活方式工具包。
- 干预内容涵盖饮食、体力活动、压力管理、戒烟限酒和服药依从性等多方面。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lifestyle modification, including dietary interventions, physical activity, and stress management, has proven crucial in the non-pharmacological management of cardiometabolic diseases. However, the implementation of these interventions in the context of cardiometabolic multimorbidity (CMM) within the unique demographic and cultural milieu of India is inadequately explored, despite Indians exhibiting distinct susceptibility to cardiovascular diseases. This community-based study aims to address existing knowledge gaps by implementing a culturally tailored lifestyle toolkit based on the WHO-HEARTS framework among individuals with CMM and exploring the intergenerational preventive dimension. The study adopts a two-arm non-blinded cluster randomised controlled trial (c-RCT) design to include adults diagnosed with CMM, defined by the presence of two or more of diabetes mellitus, hypertension, stroke, or coronary heart disease, aged 18 years and above, providing informed consent, and agreeing to follow-up. The trial spans the 'Epidemiology of Non-communicable Diseases In Rural Areas' (ENDIRA) cohort in Ernakulam, Kerala. The intervention, 'SHRADDHA lifestyle toolkit', integrates guidance on diet, physical activity, stress management, tobacco and alcohol cessation, and drug adherence. It leverages frontline health workers and a digital health platform for implementation. Measurements involve use of point-of-care devices and digital tools. The study duration is 24 months, with a sample size of 2000 participants distributed across 18 clusters. Statistical analysis includes repeated-measures ANOVA and multilevel models, employing an intention-to-treat approach. The study's novelty lies in its holistic approach, addressing various facets of CMM comprehensively.Trial registration: The trial has been registered with the Clinical Trial Registry of India (CTRI) Reference Number-CTRI/2025/08/092529. Registered on August 6, 2025.
引用
- Sreedevi A, Janakiram C, Sasidharan N, et al. Implementing a lifestyle toolkit in individuals with cardiometabolic multimorbidity: study protocol for a cluster randomised, type III effectiveness-implementation trial (SHRADDHA-CMM). Trials. 2026. PMID: 42231468. doi:10.1186/s13063-026-09793-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。